patient management

Comparative risks of dementia and Parkinson’s disease with GLP-1 RAs versus other oral glucose-lowering medications in obese patients with type 2 diabetes: a large real-world cohort study

Study Overview This study investigates the comparative risks associated with dementia and Parkinson’s disease in obese individuals suffering from type

Comparative risks of dementia and Parkinson’s disease with GLP-1 RAs versus other oral glucose-lowering medications in obese patients with type 2 diabetes: a large real-world cohort study Read Post »

Scroll to Top